Publications by authors named "L Sutherland"

Introduction: No clear guidelines exist for unfractionated heparin (UFH) monitoring in adult patients on veno-arterial extracorporeal life support (VA-ECLS) for refractory cardiogenic shock. In this study, we sought to compare outcomes between anti-factor Xa (FXa) and activated partial thromboplastin time (aPTT) strategies for UFH monitoring during VA-ECLS.

Methods: This is a single-center, retrospective review of VA-ECLS patients who received UFH in the cardiothoracic intensive care unit between July 2019 and November 2023.

View Article and Find Full Text PDF

The northern North American Cordillera is a globally significant center of endemism. In western North America, imperiled arid steppe habitats support a number of unique species, including several endemic lichens. However, processes driving diversification and endemism in this region remain unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at how to manage blood thinners after people got a special heart device called HeartMate 3.
  • It compared two methods for checking the right dose of a blood thinner called unfractionated heparin (UFH).
  • There were no big differences in bleeding or clotting problems between the two methods, but more research is needed to know which one is better.
View Article and Find Full Text PDF

Background: Metformin is a hypoglycaemic medication that has been proposed to treat or prevent preeclampsia. Combining national birth data from Scotland and Sweden, we investigated whether metformin used during pregnancy was associated with an altered risk of developing a hypertensive disorder of pregnancy.

Methods: We utilised data from two population-based cohorts: Scotland (2012-2018) and Sweden (2007-2019).

View Article and Find Full Text PDF
Article Synopsis
  • Sex significantly impacts cancer development, progression, and treatment responses, yet early-phase clinical trials often overlook this variable.
  • Ignoring sex differences can lead to inappropriate dosing, unrecognized toxicity risks, and missed unique responses to cancer treatments.
  • Enhancing the consideration of sex in drug development could improve the precision and effectiveness of new cancer therapies.
View Article and Find Full Text PDF